62-year-old male with history of prostate cancer scheduled for surgery. Evaluate for disease and assess for nerve sparing. PELVIS:PROSTATE:Prostate Size: The prostate measures 4.6 cm in transverse, 3.7 cm in AP, and 3.9 cm in craniocaudal length.Peripheral Zone: In the right mid gland, there is a 1.7 x 1.3 cm ADC and T2 hypointense lesion (series 301 image 12). There is a extracapsular extension along the right posterior-lateral border close to the neurovascular bundle, and involvement is not excluded (series 301 image 11). The lesion extends from the right mid gland to the apex.Central Gland: Nodular appearance of BPH.Seminal Vesicles: No evidence of seminal vesicle invasion.Extracapsular Extension: As aboveBLADDER: No significant abnormality noted.LYMPH NODES: Subcentimeter external iliac lymph nodes are not enlarged by criteria. Evaluation of the lymph nodes at the aortic bifurcation is significantly limited due to artifact. Consider CT exam.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.In the right mid gland peripheral zone extending to the apex, there is a 1.7 x 1.3 cm ADC and T2 hypointense with extracapsular extension along the right posterior-lateral border close to the neurovascular bundle, and involvement is not excluded. PI-RADS-5 PI-RADS™ v2 Assessment Categories:PI-RADS 1 – Very low (clinically significant cancer is highly unlikely to be present) PI-RADS 2 – Low (clinically significant cancer is unlikely to be present)PI-RADS 3 – Intermediate (the presence of clinically significant cancer is equivocal)PI-RADS 4 – High (clinically significant cancer is likely to be present) PI-RADS 5 – Very high (clinically significant cancer is highly likely to be present)https://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/PIRADS/PIRADS%20V2.pdf